IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
Human medicines European public assessment report (EPAR): Zokinvy, lonafarnib, Date of authorisation: 18/07/2022, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Stalevo, levodopa,carbidopa,entacapone, Date of authorisation: 17/10/2003, Revision: 30, Status: Authorised
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Efficacy Working Party (EWP-V) 2025
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 9-12 December 2024
List of medicines currently in PRIME scheme
Checklist for annual updates for parallel distribution: guidance for industry
Checklist for initial notifications for parallel distribution: guidance for industry
Certification of medicinal products
Information package for certificates of medicinal products issued by the European Medicines Agency